<DOC>
	<DOCNO>NCT01045291</DOCNO>
	<brief_summary>The purpose research study evaluate safety new pace method ( Fusion Pacing ) heart failure patient ejection fraction ( EF ) great 50 % period 4 month , determine effect different measure heart failure . This new pace method may allow heart pump efficiently . Participation study last approximately 8 month .</brief_summary>
	<brief_title>Pacing Heart Failure With Preserved Ejection Fraction</brief_title>
	<detailed_description>Patients EF great 50 % regional mechanical delay &gt; = 65ms ( indication mechanical dyssynchrony ) receive implantable cardioverter defibrillator ( ICD ) special pacing feature . When feature active , device wil pace leave ventricle target improve pump efficiency . Patients feature active 4 month inactive 4 month . The order randomize patient know whether pace active . Echocardiography , biomarkers , exercise testing , quality life ( QOL ) test device information use compare patient 's status feature active vs. inactive .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients quantitative ejection fraction ( EF ) great 50 percent Patients active heart failure ( symptomatic American Heart Association/American College Cardiology stage C ) despite optimal medication Patients great 18 year age Patients willing able give inform consent Patients available appropriate followup time length study Patients able complete cardiopulmonary exercise ( CPX ) test Patients expect lifespan great 12 month beyond study enrollment Patients regional mechanical delay ( RMD ) ( septallateral ) great 65 millisecond Patients undergone cardiac surgery 60 day prior enrollment Patients myocardial infarction 90 day prior enrollment Patients hemodynamically significant uncorrected cardiac valvular disease Patients active myocarditis amyloidosis ( document ) Patients permanent pacemaker Patients creatinine great 2 milligram per milliliter estimate glomerular filtration rate ( eGFR ) less 30 50 milliliter per hour Patients permanent chronic sustain atrial fibrillation ( fibrillation last 7 day time ) Patients PR interval great 250 millisecond Patients severe chronic obstructive pulmonary disease Patients high risk coronary artery disease Patients expect become pregnant study Patients enrol concurrent study could confound result study Patients hypertrophic cardiomyopathy ( obstructive nonobstructive ) Patients infiltrative disease restrictive cardiomyopathy Patients indication percutaneous coronary intervention ( PCI ) enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>